LN-144

Unmet Medical Need

We aim to cure, to revolutionize the cancer-treatment paradigm, to develop and optimize TIL technology, to switch natural immune defense to anti-cancer immune-offense, to yield clinical outcomes that redefine success in cancer treatment and which give real hope to patients that have none.